XML 27 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity
9 Months Ended
Sep. 30, 2020
Stockholders Equity Note [Abstract]  
Stockholders' Equity

NOTE 8 – STOCKHOLDERS’ EQUITY

The Company’s amended and restated certificate of incorporation filed on December 14, 2017, authorizes the Company to issue 10,000,000 shares of preferred stock and 50,000,000 shares of common stock.

Stock Options

On June 23, 2020, the Company awarded 412,125 stock options to a member of senior management.  The awards contain a market condition whereby the awards will vest based on increases in the stock price measured at June 30 and December 31 over the three year period following the grant date.  The awards will become fully vested when the stock price meets or exceeds $5.50 per share on any measurement date.

A summary of stock option activity under each of the Company’s stock option plans during the nine months period ended September 30, 2020:

 

 

 

Stock Options Outstanding

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Life (in years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding at January 1, 2020

 

 

1,686,444

 

 

$

1.30

 

 

 

4.22

 

 

$

1,535,987

 

Granted

 

 

432,125

 

 

$

2.71

 

 

 

 

 

 

 

 

 

Forfeited / Cancelled

 

 

(38,197

)

 

$

2.51

 

 

 

 

 

 

 

 

 

Exercised

 

 

(744,951

)

 

$

0.87

 

 

 

 

 

 

 

 

 

Outstanding at  September 30, 2020

 

 

1,335,421

 

 

$

1.81

 

 

 

6.66

 

 

$

616,432

 

Exercisable at September 30, 2020

 

 

845,649

 

 

$

1.53

 

 

 

5.01

 

 

$

616,323

 

Vested and expected to vest at September 30, 2020

 

 

1,320,728

 

 

$

1.81

 

 

 

6.63

 

 

$

616,429

 

 

The following table presents details of the assumptions used to calculate the weighted-average grant date fair value of common stock options granted by the Company:

 

 

 

For the Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

Expected term (in years)

 

5.04

 

 

4.65 - 5.87

 

Expected volatility

 

43.5 - 47.80%

 

 

43.7 - 44.4%

 

Risk-free interest rate

 

 

0.33

%

 

2.49 - 2.55%

 

Weighted average grant date fair value per share

 

$

0.83

 

 

$

1.07

 

Grant date fair value of options vested

 

$

545,388

 

 

$

574,524

 

Intrinsic value of options exercised

 

$

917,625

 

 

$

551,134

 

 

As of September 30, 2020, the amount of unearned stock-based compensation estimated to be expensed from 2020 through 2025 related to unvested common stock options is $370,072, net of estimated forfeitures. The weighted-average period over which the unearned stock-based compensation is expected to be recognized is 2.38 years.

If there are any modifications or cancellations of the underlying unvested awards, the Company may be required to accelerate, increase or cancel any remaining unearned stock-based compensation expense or calculate and record additional expense.  Future stock-based compensation expense and unearned stock-based compensation will increase to the extent that the Company grants additional common stock options or other stock-based awards.

Restricted Stock Units

Restricted stock units may be granted at the discretion of the compensation committee of the Board of Directors under the Company’s 2017 Equity Incentive Plan that was adopted on October 10, 2017 (the “2017 Plan”) in connection with the hiring and retention of personnel and are subject to certain conditions.  Restricted stock units generally vest quarterly or semi-annually over a period of one to three years and are typically forfeited if employment is terminated before the restricted stock unit vest.  The compensation expense related to the restricted stock units is calculated as the fair value of the common stock on the grant date and is amortized to expense over the vesting period and is adjusted for estimated forfeitures.

The Company’s restricted stock unit activity for the nine months ended September 30, 2020 is as follows:

 

 

 

Restricted Stock Units

 

 

 

Number of

Shares

 

 

Weighted

Average Grant

Date Fair Value

 

Unvested at January 1, 2020

 

 

216,670

 

 

$

3.02

 

Granted

 

 

554,251

 

 

$

2.51

 

Vested

 

 

(148,751

)

 

$

3.15

 

Cancelled

 

 

(38,333

)

 

$

2.41

 

Unvested at September 30, 2020

 

 

583,837

 

 

$

2.54

 

 

As of September 30, 2020, there was $1,048,715 of unrecognized compensation cost related to unvested restricted stock units which is expected to be recognized over a weighted average period of 2.42 years.

Stock-based compensation expense for the three and nine month periods ended September 30, 2020 and 2019 was comprised of the following:

 

 

 

For the Three Months Ended September 30,

 

 

For the Nine Months Ended September 30,

 

Stock-based compensation classified as:

 

2020

 

 

2019

 

 

2020

 

 

2019

 

General and administrative

 

$

171,636

 

 

$

120,188

 

 

$

373,667

 

 

$

357,679

 

Production

 

 

15,118

 

 

 

18,140

 

 

 

50,856

 

 

 

52,131

 

Marketing and selling

 

 

15,696

 

 

 

15,011

 

 

 

50,062

 

 

 

44,472

 

Research and development

 

 

7,830

 

 

 

11,518

 

 

 

28,834

 

 

 

35,858

 

 

 

$

210,280

 

 

$

164,857

 

 

$

503,419

 

 

$

490,140

 

 

Warrants

The following table summarizes the Company’s warrant activity during the nine months ended September 30, 2020:

 

 

 

Number of

Warrants

 

 

Weighted

Average

Exercise Price

 

Warrants outstanding – January 1, 2020

 

 

630,947

 

 

$

4.16

 

Warrants granted

 

 

-

 

 

$

-

 

Warrants exercised

 

 

(78,948

)

 

$

0.76

 

Warrants outstanding – September 30, 2020

 

 

551,999

 

 

$

4.65